Reversion in vivo after inoculation of a molecular proviral DNA clone of simian immunodeficiency virus with a cytotoxic-T-lymphocyte escape mutation

J Virol. 2005 Sep;79(17):11529-32. doi: 10.1128/JVI.79.17.11529-11532.2005.

Abstract

Vaccine-based control of the replication of a simian immunodeficiency virus (SIV), SIVmac239, in macaques has recently been shown. In the process of the control, a mutant virus escaping from epitope-specific cytotoxic-T-lymphocyte (CTL) responses was rapidly selected and contained. In this study, we show that the wild-type virus appeared and became predominant in the absence of the epitope-specific CTL after inoculation of naive macaques with a molecular clone DNA of the CTL escape mutant SIV. This is the first report describing reversion in vivo from an inoculated, molecular proviral DNA clone of immunodeficiency virus with a CTL escape mutation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS Vaccines / administration & dosage*
  • Amino Acid Sequence
  • Animals
  • DNA, Viral / administration & dosage*
  • Epitopes, T-Lymphocyte
  • Gene Products, gag / genetics
  • Macaca fascicularis
  • Molecular Sequence Data
  • Mutation
  • Proviruses
  • Simian Acquired Immunodeficiency Syndrome / immunology*
  • Simian Acquired Immunodeficiency Syndrome / virology
  • Simian Immunodeficiency Virus / genetics
  • Simian Immunodeficiency Virus / physiology*
  • T-Lymphocytes, Cytotoxic / immunology*
  • Vaccination*
  • Virus Replication

Substances

  • AIDS Vaccines
  • DNA, Viral
  • Epitopes, T-Lymphocyte
  • Gene Products, gag